AMRZ Fundamental Analysis - AMRIZE LTD

Fundamental Rating

AMRZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. Both the profitability and financial health of AMRZ have multiple concerns. AMRZ has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMRZ was profitable.

1.2 Ratios

AMRZ has a Return On Assets (5.36%) which is in line with its industry peers.

The Return On Equity of AMRZ (10.25%) is comparable to the rest of the industry.

Looking at the Return On Invested Capital, with a value of 7.38%, AMRZ is in line with its industry, outperforming 53.85% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	5.36%
ROE	10.25%
ROIC	7.38%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AMRZ has a better Profit Margin (10.89%) than 61.54% of its industry peers.

With a decent Operating Margin value of 18.16%, AMRZ is doing good in the industry, outperforming 69.23% of the companies in the same industry.

AMRZ has a Gross Margin of 26.23%. This is in the lower half of the industry: AMRZ underperforms 69.23% of its industry peers.

		Industry Rank	Sector Rank
OM	18.16%
PM (TTM)	10.89%
GM	26.23%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMRZ is destroying value.

AMRZ has about the same amout of shares outstanding than it did 1 year ago.

Compared to 1 year ago, AMRZ has an improved debt to assets ratio.

2.2 Solvency

AMRZ has an Altman-Z score of 2.35. This is not the best score and indicates that AMRZ is in the grey zone with still only limited risk for bankruptcy at the moment.

AMRZ has a Altman-Z score of 2.35. This is comparable to the rest of the industry: AMRZ outperforms 46.15% of its industry peers.

A Debt/Equity ratio of 0.52 indicates that AMRZ is somewhat dependend on debt financing.

With a Debt to Equity ratio value of 0.52, AMRZ perfoms like the industry average, outperforming 46.15% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.52
Debt/FCF	N/A
Altman-Z	2.35

ROIC/WACC0.77

WACC9.62%

2.3 Liquidity

A Current Ratio of 1.38 indicates that AMRZ should not have too much problems paying its short term obligations.

The Current ratio of AMRZ (1.38) is worse than 69.23% of its industry peers.

AMRZ has a Quick Ratio of 1.38. This is a bad value and indicates that AMRZ is not financially healthy enough and could expect problems in meeting its short term obligations.

AMRZ has a worse Quick ratio (0.85) than 69.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.38
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.26% over the past year.

The Revenue has been growing slightly by 0.23% in the past year.

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-9.5%

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-0.71%

3.2 Future

Based on estimates for the next years, AMRZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.65% on average per year.

AMRZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.08% yearly.

EPS Next Y5.82%

EPS Next 2Y10.91%

EPS Next 3Y12.82%

EPS Next 5Y11.65%

Revenue Next Year2.98%

Revenue Next 2Y4.01%

Revenue Next 3Y4.86%

Revenue Next 5Y5.08%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AMRZ is valuated rather expensively with a Price/Earnings ratio of 22.36.

AMRZ's Price/Earnings ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 61.54% of the companies in the same industry.

AMRZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.15.

A Price/Forward Earnings ratio of 18.13 indicates a rather expensive valuation of AMRZ.

69.23% of the companies in the same industry are more expensive than AMRZ, based on the Price/Forward Earnings ratio.

AMRZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.22.

		Industry Rank	Sector Rank
PE	22.36
Fwd PE	18.13

4.2 Price Multiples

69.23% of the companies in the same industry are more expensive than AMRZ, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	11.1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

AMRZ's earnings are expected to grow with 12.82% in the coming years. This may justify a more expensive valuation.

PEG (NY)3.84

PEG (5Y)N/A

EPS Next 2Y10.91%

EPS Next 3Y12.82%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMRZ does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMRIZE LTD

NYSE:AMRZ (12/2/2025, 8:26:35 PM)

Premarket: 52.26 +0.84 (+1.63%)

51.42

-0.62 (-1.19%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryConstruction Materials

Earnings (Last)10-28 2025-10-28/amc

Earnings (Next)N/A N/A

Inst Owners37.75%

Inst Owner ChangeN/A

Ins Owners7.13%

Ins Owner Change-33264.5%

Market Cap28.44B

Revenue(TTM)11.70B

Net Income(TTM)1.27B

Analysts78.67

Price TargetN/A

Short Float %1.97%

Short Ratio2.35

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)-17.36%

EPS NY rev (1m)-5.33%

EPS NY rev (3m)-13.08%

Revenue NQ rev (1m)6.41%

Revenue NQ rev (3m)5.01%

Revenue NY rev (1m)-0.13%

Revenue NY rev (3m)-1.28%

Valuation

		Industry Rank	Sector Rank
PE	22.36
Fwd PE	18.13
P/S	2.43
P/FCF	N/A
P/OCF	N/A
P/B	2.29
P/tB	17.69
EV/EBITDA	11.1

EPS(TTM)2.3

EY4.47%

EPS(NY)2.84

Fwd EY5.51%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS21.16

BVpS22.48

TBVpS2.91

PEG (NY)3.84

PEG (5Y)N/A

Graham Number34.11

Profitability

		Industry Rank	Sector Rank
ROA	5.36%
ROE	10.25%
ROCE	10.3%
ROIC	7.38%
ROICexc	7.59%
ROICexgc	15.69%
OM	18.16%
PM (TTM)	10.89%
GM	26.23%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0.52
Debt/FCF	N/A
Debt/EBITDA	2.15
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.38
Quick Ratio	0.85
Altman-Z	2.35

F-ScoreN/A

WACC9.62%

ROIC/WACC0.77

Cap/Depr(3y)69.39%

Cap/Depr(5y)N/A

Cap/Sales(3y)5.14%

Cap/Sales(5y)N/A

Profit Quality(3y)137.06%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-9.5%

EPS Next Y5.82%

EPS Next 2Y10.91%

EPS Next 3Y12.82%

EPS Next 5Y11.65%

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-0.71%

Revenue Next Year2.98%

Revenue Next 2Y4.01%

Revenue Next 3Y4.86%

Revenue Next 5Y5.08%

EBIT growth 1Y13.63%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year47.27%

EBIT Next 3Y20.21%

EBIT Next 5Y14.65%

FCF growth 1Y16.64%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y12.08%

OCF growth 3YN/A

OCF growth 5YN/A

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

ChartMill assigns a fundamental rating of 2 / 10 to AMRZ.

What is the valuation status for AMRZ stock?

ChartMill assigns a valuation rating of 3 / 10 to AMRIZE LTD (AMRZ). This can be considered as Overvalued.

How profitable is AMRIZE LTD (AMRZ) stock?

AMRIZE LTD (AMRZ) has a profitability rating of 2 / 10.

What are the PE and PB ratios of AMRIZE LTD (AMRZ) stock?

The Price/Earnings (PE) ratio for AMRIZE LTD (AMRZ) is 22.36 and the Price/Book (PB) ratio is 2.29.

Can you provide the financial health for AMRZ stock?

The financial health rating of AMRIZE LTD (AMRZ) is 2 / 10.

AMRIZE LTD (AMRZ) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

What is the valuation status for AMRZ stock?

How profitable is AMRIZE LTD (AMRZ) stock?

What are the PE and PB ratios of AMRIZE LTD (AMRZ) stock?

Can you provide the financial health for AMRZ stock?